Related Experiment Video
Updated: Jul 20, 2026
Multiplex Detection of Bacteria in Complex Clinical and Environmental Samples using Oligonucleotide-coupled Fluorescent Microspheres
Published on: October 23, 2011
Integrated Microfluidic Sample-to-Answer System for Direct Nucleic Acid-Based Detection of Group B Streptococci in
Xin Ye1, Yang Li2, Xueen Fang1
1Department of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai 200433, P. R. China.
Insights
A new microfluidic system enables rapid, accurate detection of Group B Streptococcus (GBS) in pregnant women. This integrated sample-to-answer technology provides results in about 45 minutes, improving patient outcomes.
Area of Science:
- Biomedical Engineering
- Molecular Diagnostics
- Microfluidics
Background:
- Group B Streptococcus (GBS) poses significant health risks to mothers and infants.
- Current diagnostic methods (bacterial culture, PCR) are slow and complex.
- Rapid and accurate GBS detection is critical for timely intervention.
Purpose of the Study:
- To develop an integrated microfluidic system for rapid nucleic acid-based GBS detection.
- To demonstrate a novel dynamical reaction mechanism for GBS nucleic acid amplification.
- To enable sample-to-answer GBS detection directly from clinical samples.
Main Methods:
- Established an integrated microfluidic system combining cell lysis, nucleic acid purification, amplification, and detection.
- Utilized a novel Bst/FEN1-based nucleic acid amplification strategy.
- Validated the system using vaginal/anal swab samples.
Main Results:
- Achieved rapid analysis in approximately 45 minutes with 98% accuracy.
- Demonstrated a low detection limit (500 CFU/mL) and perfect specificity.
- Showcased excellent stability (CV < 3%) and anti-interference performance.
Conclusions:
- The developed microfluidic system offers a fast, accurate, and stable diagnostic tool for GBS detection.
- The novel amplification mechanism and integrated system show potential for broader pathogen detection applications.
- This technology can significantly improve clinical diagnostics for maternal and infant health.
Abstract:
The group B Streptococcus (GBS) is a type of pathogen that seriously threatens the health of mothers and infants. Prompt and timely diagnosis is crucial for good patient outcomes. However, the traditional bacterial culture and polymerase chain reaction methods are limited by their speed and involve complex operating procedures. Herein, we successfully established an integrated microfluidic sample-to-answer system for nucleic acid-based detection of GBS directly in vaginal/anal swab samples. Meanwhile, we demonstrated a dynamical reaction mechanism of Bst/FEN1-based nucleic acid amplification, which differs from traditional Bst-based isothermal amplification strategies. The system integrates cell lysis and nucleic acid purification, separation, amplification, and detection, enabling rapid (about 45 min to the entire analysis) and highly accurate (98% accuracy) analysis in a clinical setting. Experimental results show that the system offers a good detection limit (500 CFU/mL), perfect specificity (no cross-reactivity with 25 other common pathogens), excellent stability (coefficient of variation less than 3%), and good anti-interference performance. This novel system holds great potential as a nucleic acid-based diagnostic tool in clinical applications for detecting not only GBS but also other types of pathogens.
Related Concept Videos
01:25Rapid Identification of Pathogens
01:24Automated Microbial Diagnostics